Midlife women on weight loss drugs: what happens to muscle and bone?
NCT ID NCT07422987
First seen Feb 23, 2026 · Last updated Apr 30, 2026 · Updated 6 times
Summary
This study looks at how estrogen levels influence changes in body composition, muscle function, and bone health in women aged 35-60 who are starting a GLP-1RA medication for weight loss. Researchers will measure weight, lean and fat mass, bone density, and muscle strength. The goal is to understand how these drugs affect the body beyond weight loss, especially in midlife women.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BODY COMPOSITION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The University of Kansas Medical Center
RECRUITINGKansas City, Kansas, 66160, United States
Conditions
Explore the condition pages connected to this study.